I. Introduction
Multiplexed protein detection is emerging as an important tool for analyzing cellular networks and characterizing complex diseases, where more traditional nucleic acid assays have proven insufficient [1]. Protein microarrays, a primary multiplex detection platform, have already demonstrated efficacy in analyzing and characterizing colon cancer cells [2], breast cancer biomarkers [3], and a myriad of human autoimmune diseases [4]. These technologies are limited, however, by dependence on fluorescently labeled generic binders, where cross-reactivity at the reporter level bounds assay specificity [1]. Additionally, unbound labeled reporters prevent real-time detection and quantification of binding events, as these must be washed away prior to optical interrogation. These limitations can be surmounted with label-free, mass-based sensing techniques, but only if such techniques can overcome their own technological barriers to multiplexed detection.